ContributorsPublishersAdvertisers

Newly approved therapy for polycythemia vera enables physicians to focus on treating the totality of this debilitating rare blood cancer earlier in the journey

onclive.com
 2021-11-30

A new therapy for polycythemia vera (PV), a rare and life-threatening blood cancer,1 could fundamentally change how physicians approach managing this chronic disease and improve the outlook for patients. The rare nature of PV means the disease is often overlooked, with symptoms that can become more debilitating over time...

www.onclive.com

Comments / 0

Comments / 0